Matt Plavan

Matt Plavan, President of Arcadia Specialty Genomics

Matthew Plavan joined Arcadia as chief financial officer in September 2016 and serves as president of Arcadia Specialty Genomics, a strategic business unit delivering innovations in cannabis. He brings more than 30 years of financial and executive leadership experience in the ag-tech, biotech, healthcare and high technology sectors. Prior to joining Arcadia, Mr. Plavan served as CEO of Cesca Therapeutics, Inc., CFO of Strion Air, Inc. and CFO of Reason, Inc. He also held executive finance positions with McKesson Corporation and audit and advisory management positions with Ernst & Young. Mr. Plavan is a certified public accountant and earned a bachelor’s degree in business economics from the University of California, Santa Barbara.

Listen to the interview with Matt (published May 2019)